Rizzo, A.; Dall’Armellina, S.; Pizzuto, D.A.; Perotti, G.; Zagaria, L.; Lanni, V.; Treglia, G.; Racca, M.; Annunziata, S.
PSMA Radioligand Uptake as a Biomarker of Neoangiogenesis in Solid Tumours: Diagnostic or Theragnostic Factor? Cancers 2022, 14, 4039.
https://doi.org/10.3390/cancers14164039
AMA Style
Rizzo A, Dall’Armellina S, Pizzuto DA, Perotti G, Zagaria L, Lanni V, Treglia G, Racca M, Annunziata S.
PSMA Radioligand Uptake as a Biomarker of Neoangiogenesis in Solid Tumours: Diagnostic or Theragnostic Factor? Cancers. 2022; 14(16):4039.
https://doi.org/10.3390/cancers14164039
Chicago/Turabian Style
Rizzo, Alessio, Sara Dall’Armellina, Daniele Antonio Pizzuto, Germano Perotti, Luca Zagaria, Valerio Lanni, Giorgio Treglia, Manuela Racca, and Salvatore Annunziata.
2022. "PSMA Radioligand Uptake as a Biomarker of Neoangiogenesis in Solid Tumours: Diagnostic or Theragnostic Factor?" Cancers 14, no. 16: 4039.
https://doi.org/10.3390/cancers14164039
APA Style
Rizzo, A., Dall’Armellina, S., Pizzuto, D. A., Perotti, G., Zagaria, L., Lanni, V., Treglia, G., Racca, M., & Annunziata, S.
(2022). PSMA Radioligand Uptake as a Biomarker of Neoangiogenesis in Solid Tumours: Diagnostic or Theragnostic Factor? Cancers, 14(16), 4039.
https://doi.org/10.3390/cancers14164039
